DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE. Mediterr J Hematol Infect Dis [Internet]. 2020 Feb. 26 [cited 2026 May 4];12(1):e2020016. Available from: https://www.mjhid.org/mjhid/article/view/2020.016